Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

22.97 +1.42 (+6.59%)
Streaming Delayed Price Updated: 3:36 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Why Tandem Diabetes (TNDM) Shares Are Getting Obliterated Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 6% in the afternoon session after investor concerns were sparked by a disappointing financial outlook from peer DexCom.... 
Via StockStory
Topics Supply Chain
News headline image
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 1.6% in the afternoon session after the company announced a positive update on a clinical study for its Control-IQ... 
Via StockStory
Topics Economy Government World Trade
News headline image
DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor ↗
Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify. 
Via Benzinga
Topics Death Lawsuit
News headline image
Healthcare Technology Stocks Q2 Highlights: Tandem Diabetes (NASDAQ:TNDM)
Looking back on healthcare technology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Tandem Diabetes (NASDAQ:TNDM) and its peers. 
Via StockStory
News headline image
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Breaking Down Tandem Diabetes Care: 13 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
News headline image
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics World Trade
News headline image
Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
Why Tandem Diabetes (TNDM) Shares Are Trading Lower Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 5.5% in the afternoon session after the U.S. government opened an investigation into the national security implications of... 
Via StockStory
Topics Economy World Trade
News headline image
1 Growth Stock to Add to Your Roster and 2 We Brush Off
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who... 
Via StockStory
News headline image
TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Why Tandem Diabetes (TNDM) Stock Is Up Today
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 5% in the morning session after the company announced the publication of a study showing its automated insulin delivery... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
1 Small-Cap Stock to Keep an Eye On and 2 We Turn Down
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels
From Tandem Diabetes Care
Via Business Wire
News headline image
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Jim Cramer: This Is The Right Time To Buy This Energy Stock ↗
Mad Money's Jim Cramer looks at Phillips 66 and Intuitive Surgical, as well as Tandem Diabetes Care and Cintas. 
Via Benzinga
News headline image
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM
From Rosen Law Firm
Via Business Wire
News headline image
Beyond The Numbers: 12 Analysts Discuss Tandem Diabetes Care Stock ↗
 
Via Benzinga
News headline image
Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones
From Tandem Diabetes Care, Inc.
Via Business Wire
News headline image
1 Volatile Stock with Exciting Potential and 2 We Avoid
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
News headline image
3 Healthcare Stocks with Open Questions
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
News headline image
Sirius XM, Lovesac, Rogers, Tandem Diabetes, and Altice Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key reason for this... 
Via StockStory
Topics Artificial Intelligence Economy World Trade
News headline image
3 Unprofitable Stocks with Questionable Fundamentals
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.